Review of authorship for COVID‐19 research conducted during the 2020 first‐wave epidemic in Africa reveals emergence of promising African biomedical research and persisting asymmetry of international collaborations.

Objectives: The contribution of African authors to the biomedical literature is small. We evaluated the African and non‐African scientific production published in the international literature on the COVID‐19 in Africa during the first year of the epidemic (2020). Methods: Papers on COVID‐19 in Africa were extracted from the Medline (PubMed) database for bibliometric analysis including the proportions of three leading and last authors by study type, study country, authors' and laboratories/institutions' countries of affiliation and journal ranking. Results: A total of 160 articles fulfilling the inclusion criteria were analysed. The majority (91.3%) was produced by half (53.7%) of African countries, with important regional disparities, and generally without sources of funding mentioned. The majority (>85.0) of authors in lead positions (first, second, third and last authors) were Africans. Only a small number (8.7%) of studies on COVID‐19 in Africa were carried out by laboratories not on the African continent (mainly Europe, USA and China) and generally received funding. The last and first authors were more frequently of non‐African origin in journals with an Impact Factor ranking ≥1, and more frequently of African origin in journals with a lower ranking (< 1). The first and last non‐African authors tended to report their studies in high ranking ≥1 journals. Conclusions: Our study demonstrates that the emergence of promising African research capable of publishing in indexed but low‐impact factor medical journals and reveals the persistence of a North‐South asymmetry in international cooperation in biomedical research with Africa. [ABSTRACT FROM AUTHOR]